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In 2009, a pathologist with sporadic Creutzfeldt–
Jakob Disease (sCJD) was reported to the Spanish reg-
istry. This case prompted a request for information on 
health-related occupation in sCJD cases from coun-
tries participating in the European Creutzfeldt Jakob 
Disease Surveillance network (EuroCJD). Responses 
from registries in 21 countries revealed that of 8,321 
registered cases, 65 physicians or dentists, two of 
whom were pathologists, and another 137 healthcare 
workers had been identified with sCJD. Five countries 
reported 15 physicians and 68 other health profession-
als among 2,968 controls or non-cases, suggesting no 
relative excess of sCJD among healthcare profession-
als. A literature review revealed: (i) 12 case or small 
case-series reports of 66 health professionals with 
sCJD, and (ii) five analytical studies on health-related 
occupation and sCJD, where statistically significant 
findings were solely observed for persons working at 
physicians’ offices (odds ratio: 4.6 (95 CI: 1.2–17.6)). 
We conclude that a wide spectrum of medical speci-
alities and health professions are represented in sCJD 
cases and that the data analysed do not support any 
overall increased occupational risk for health profes-
sionals. Nevertheless, there may be a specific risk in 
some professions associated with direct contact with 
high human-infectivity tissue.
Introduction 
Creutzfeldt–Jakob disease (CJD) is a fatal neurodegen-
erative disease characterised by deposition of a path-
ological isoform of the normal cellular prion protein 
(PrPC) [1]. The annual CJD incidence worldwide is 1–2 
per million population [2]. CJD exists in various forms: 
genetic, caused by mutations in the PRNP gene encod-
ing PrPC, acquired (variant and iatrogenic) and spo-
radic. Most cases have sporadic CJD (sCJD) – the cause 
of which is unknown. Occupational risk related to sCJD 
has been assessed in several case–control studies as 
a secondary study objective, with inconsistent results 
[3-7] and there have been occasional reports of health 
professionals with sCJD [8-12].
Occupation has not been included as a variable in all 
CJD surveillance protocols [13]. Nonetheless, there is 
concern about potential occupational excess risk of 
sCJD among health professions, as shown by a recent 
study on guidelines in European Union (EU) Member 
States and Norway for the prevention of CJD transmis-
sion in medical settings. This study showed that 12 of 
the 17 contributing countries had specific recommen-
dations targeted at minimising occupational exposure; 
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eight of the 12 had systems for reporting or registering 
work-related incidents at hospitals or laboratories [14].
In March 2009, a CJD case was reported to the Spanish 
CJD registry, who was classified as having sporadic 
CJD. As the patient was an experienced general pathol-
ogist and neuropathologist, it was speculated that the 
disease might have been a result of the person’s pro-
fessional activities. The event was commented on in 
medical, scientific and mass media in Spain and else-
where, e.g. [15]. The patient died after a four-month dis-
ease course, characterised mainly by cognitive decline, 
ataxia and myoclonus. The disease prion protein sub-
type, i.e. strain, was confirmed histochemically and 
biochemically as MM1, the most common subtype [2]. 
Risk factors for developing CJD, including blood trans-
fusion, iatrogenic exposure (e.g. to dura mater, cadav-
eric pituitary-derived growth hormone) and mutations 
in the PRNP gene, were not identified. Assessment of 
the patient’s routine hospital work indicated that the 
patient had had a history of minor injuries during post-
mortem examinations (personal communication, E. 
García-Albea, April 2009).
Following notification of this patient, the Spanish 
registry circulated a request for information to 
each national surveillance team participating in the 
European Creutzfeldt Jakob Disease Surveillance 
Network (EuroCJD), which dates back to 1993 and cur-
rently encompasses 25 collaborating centres in EU 
Member States and European Free Trade Association 
(EFTA) countries and a further eight in countries around 
the world, including Australia, Canada and Japan [16]. 
These centres provide data from national registries 
either through the EuroCJD website or, as with Japanese 
data, at regular network meetings. The request asked 
for the following: (i) information on the diagnosis 
(year of birth and death, sex and place of residence) of 
reported cases of sporadic CJD among active or retired 
pathologists from 1996 onwards; and (ii) comments 
based on personal experience of occupational risk and 
CJD among health professionals, including technicians 
working at pathology laboratories.
There has been limited systematic research targeted at 
identifying occupational risk factors for sCJD in health-
care settings. This paper reports on the data supplied 
to the Spanish CJD registry in response to the request, 
and on the results of two literature reviews of sCJD – 
one on case reports involving health professionals and 
the other on epidemiologically assessed healthcare-
related occupational risk of sCJD.
Methods
Individualised occupational data from 
national CJD surveillance teams
The Spanish CJD registry obtained answers in English 
to at least one of the requests for information from 21 
national surveillance teams. The amount of information 
provided varied: in general, only data that had already 
been registered was reported; with regard to occupa-
tional history in CJD – recorded by profession or activ-
ity branch – several countries provided information on 
people in whom CJD had been excluded or on controls.
The data received were divided into two groups, for 
further analysis – one describing health professionals 
who were sCJD cases and the other describing health 
professionals among controls or non-cases. We did 
not attempt a formal epidemiological assessment of 
healthcare-related occupational risk of sCJD based on 
this information, for instance using a case–control 
design.
Case reports of sCJD among health professionals
Countries with available registry data on cases’ occupa-
tions sent individualised data on physicians with neu-
ropathologically confirmed or probable sCJD or other 
types of CJD [17,18]. Some countries provided such 
data on other health professions. In the few instances 
in which occupation as a pathologist was identified, 
professional experience or job duration at a laboratory 
or department was specified. The results were tabu-
lated, using the original definitions from the countries’ 
Box
Search terms used in first step of two literature searches 
on sporadic Creutzfeldt–Jakob disease (sCJD) in health 
professionals and analytical studies on occupational risk 
of sCJD for health professions and selection criteria used 
in a second step, reported 1 January 1989–1 October 2011
MEDLINE
The search strategy was based on the following medical subject 
headings (MeSH) terms:
•	 prion	diseases/prions/Creutzfeldt-Jakob	syndrome;	and	
•	 health	occupations/allied	health	occupations/	occupational	
groups/occupations/occupational dentistry/case control 
studies. 
Embase
The search strategy was based on the following Emtree 
thesaurus terms:
•		prion/prion	disease/prion	protein/Creutzfeldt	Jakob	disease/
Creutzfeldt Jakob disease agent; and 
•		occupation/occupation	and	occupation-related	phenomena/
medical profession/nursing as a profession/nursing 
career/paramedical profession/professional development/
occupational accident/occupation and occupation-related 
phenomena/occupational accident/occupational disease/
occupational exposure/occupational hazard/occupational 
health/occupational health nursing/occupational health 
service/occupational medicine/occupational physician/
occupational safety/occupational therapist.
Selection criteria
Inclusion
Either specific reference to the subject (Creutzfeldt–Jakob 
disease and health profession) or analytical study design 
(either case–control or cohort), regardless of the study’s stated 
objective. 
Exclusion
Identification of the document as a letter or review, news, 
comment, congress abstract, when reference to health 
professions was not explicitly made. 
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reports. No standard occupational classification was 
used for grouping response results and each case was 
assigned to one occupational category. Frequently, the 
occupational categories corresponded to a combina-
tion of professional profiles, e.g. specialities and work 
types (clinical, administrative, laboratory, etc.). In such 
cases, the category most likely to involve direct con-
tact with human tissue or patients was selected.
Healthcare-related occupations among 
controls and non-cases
Some CJD surveillance teams with a sufficient sample 
size provided data on occupation of people with sus-
pected sCJD who were finally classified as not having 
CJD (non-cases) and also of those in control groups. 
Five EuroCJD countries with large populations – 
Germany, Italy, Japan, Spain and the United Kingdom 
(UK) – provided this type of data, both published 
and unpublished. These countries supplied data on 
physicians who were controls Italy and Japan also pro-
vided information on other health professionals who 
were non-cases. Information on different categories 
of health professionals was available for British con-
trols. Occupation was usually categorised on the basis 
of original records at registries. In a few instances, 
reporting physicians or relatives were consulted about 
the predominant activity, e.g. general practice vs radi-
ology, of the non-cases.
Literature reviews
The first step in the literature reviews sought to identify 
reports of sCJD among health professionals, whether 
reported as case studies or drawn from analytical 
studies published during 1 January 1989 to 1 October 
2011. We carried out several searches in MEDLINE and 
Embase using the medical subject headings (MeSH) 
and Emtree thesaurus terms listed in the Box, to iden-
tify case studies on CJD in health professionals and 
Diﬀerent documents identified
n=715
Failed to meet inclusion criteria  n=671 
No prion/CJD disorders                 n=170
Not occupation related                 n=214
Hospital/public health                  n=89
Secondary publication                  n=198
Potentially valid reports included for full-text review
n=44
n=4
n=12
MEDLINE
n=396
EMBASE
n=101
MEDLINE
n=273
Occupational term-based search Case–control study-based search
n=6
Case-study reports                                         n=4
Case series f rom case–control studies   n=2
n=34
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Analytical studies with no (n=33) or 
insuﬃciently described (n=1) individual health 
occupational data  
Reports assessing occupational health risk 
excluded due to non-validated diagnosis or 
devoid of sCJD cases among health professionals    
Reports issued before 1989 included 
f rom personal records
Reviewed case and case-series reports on sCJD 
among health professionals 
sCJD: sporadic Creutzfeldt–Jakob disease.
Figure 1
Literature review of case reports of sporadic Creutzfeldt–Jakob disease among health professionals, 1979–1 October 2011
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sCJD: sporadic Creutzfeldt–Jakob disease.
Diﬀerent documents identified
n=715
Failed to meet inclusion criteria  n=671 
No prion/CJD disorders                 n=170
Not occupation related                 n=214
Hospital/public health                  n=89
Secondary publication                  n=198
Potentially valid reports included for full-text review
n=44
MEDLINE
n=396
EMBASE
n=101
MEDLINE
n=273
Occupational term-based search Case–control study-based search
Reports addressing healthcare-related occupations 
n=5
S
T
E
P
O
N
E
S
T
E
P
T
W
O
Excluded reports on case studies only 
n=4
Included from personal files before 1989
 n=2
Potentially valid risk-based reports
 n=40
Reviewed reports on occupational risk assessment      
n=9
Excluded as the study focused on non-occupational 
exposures (genetic, biochemical, diagnostic, etc.) 
n=33
Reports possibly addressing but not reporting 
results on healthcare-related occupations 
n=4
Risk not assessed due to lack of health professions 
among cases
n=1
Reports providing valid risk-based data for 
healthcare-related occupations 
n=4
Figure 2
Literature review of analytical studies on occupational risk of sporadic Creutzfeldt–Jakob disease for health professionals, 
1982–1 October 2011     
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analytical studies on occupational risk of CJD for health 
professions. The initial searches yielded a total of 715 
different documents.
In a second step, two independent assessors applied 
predefined sets of inclusion and exclusion criteria 
(Box) to the titles of the retrieved documents or, where 
available, to their abstracts.
Documents that met the inclusion criteria were pro-
cessed further for full-text analysis in order to obtain 
the case description or to assess health-related occu-
pational risk of sCJD.
After the selection criteria for had been independently, 
though not always unanimously, applied to the 715 
documents by two reviewers, EAC and JPC, 671 were 
rejected and 44 selected for further analysis by both 
reviewers (Figures 1 and 2).
Case reports of sCJD among health professionals
Of the 44 documents selected for full-text review, 34 
were excluded as the studies did not examine health-
related occupations (Figure 1). Four studies that failed 
to include specific categories of health professionals 
with sCJD or in which the diagnosis of CJD was not vali-
dated were also excluded [3,6,7,19]. Six studies – four 
case reports [10-12,20] and two case–control studies, 
which provided information on health-related occu-
pations in sCJD case series [5,21] – were selected for 
data extraction. Five case studies and one case-control 
study retrieved from personal records before 1989 were 
also included [4,8,9,17,22,23]. Thus, the final analy-
sis of 12 reports included data on individual health 
professionals from case reports [8-12,17,20,22,23] 
and numbers of health professionals with sCJD from 
three reports on case–control studies [4,5,21]. These 
12 reports included sCJD cases fulfilling diagnostic 
criteria for neuropathologically confirmed sCJD or for 
probable sCJD (people in the latter category were only 
included in case–control studies) [5,24]. Where health 
professions were listed in the case series of a large 
case–control study and numbers were not reported, 
only one individual, e.g. a dentist, was counted [5].
Epidemiologically assessed healthcare-
related occupational risk of sCJD
Of the 44 documents selected for full-text review (the 
same 44 mentioned above), 40 fulfilled the inclusion 
criteria. After analysis of the texts, seven analyti-
cal studies on occupation and risk of sCJD remained 
for potential data extraction [3,5-7,19,21,25].Those 
excluded were multipurpose case–control investi-
gations that made no mention of occupation in the 
results, occupation-unrelated meta-analyses, genetic 
case–control studies and public-health occupational 
profiles derived from empirical data. Four analytical 
studies reported before 1989 were reviewed: two were 
included [4,26] and two rejected [27,28]. Nine docu-
ments [3-7,19,21,25,26] provided data on occupational 
risk but only five of these addressed healthcare-related 
occupations [5-7,19,26]. Due to the low numbers 
(absence of exposed cases) in one study [26], risk-
based data for health professions were only avail-
able from four case–control studies [5-7,19]. Reported 
associations for healthcare-related occupational risk 
obtained from these four epidemiological studies and 
raw negative findings from the above-mentioned study 
[26] were tabulated.
Results
Individualised occupational data from 
national CJD surveillance teams
Health professionals among registered sCJD cases
A total of 202 health professionals were listed among 
8,321 cases of sCJD registered by 21 respondent coun-
tries participating in EuroCJD (Table 1). Of these, 65 
(32%) were physicians and 137 were other healthcare 
workers. The highest numbers by medical special-
ity were general practitioners (n=9), surgeons (n=7), 
internists (n=7), dentists (n=4), ophthalmologists 
(n=3) and pathologists (n=2). The proportion of physi-
cians or dentists among all registered sCJD cases was 
65/8,321 (0.8%).
Health professionals among non-cases or controls
Table 2 shows individual data reported for health pro-
fessions among non-cases or controls in five countries 
(Germany, Italy, Japan, Spain and the UK). Among 83 
healthcare workers, 15 were physicians, six of whom 
had unknown specialisations, and three were sur-
geons. The percentage of physicians and dentists 
among CJD cases in Germany, Italy, Japan, Spain and 
the UK combined was 0.7% (34/4,949 (Table 1). This 
was similar to the proportion in the combined controls 
0.5% (15/2,968).
Literature reviews
Reported sCJD in health professionals
Individual occupational profiles of reported health-
related professionals with sCJD are outlined in Table 3. 
The data are derived from 12 studies, three of which 
were case–control studies. In these 12 studies, a 
total of 66 health workers with sCJD were reported, at 
least eight of whom were physicians [4,5,8-12,17,20-
23]. One report described genetic CJD with phenotype 
resembling sCJD in three Slovakian health workers 
(two nurses and one dermatologist) with a mutation in 
codon 200 of the PRNP gene [11].
The following professions have been reported in sCJD 
cases: dentists (n=5), dental surgeon (n=1), neurosur-
geons (n=2), pathologist (n=1), internist with training 
in pathology (n=1) and orthopaedic surgeon who had 
worked with sheep and human dura mater for indus-
trial purposes (n=1) [12]. The majority of the remaining 
health professionals were nurses, two of whom had 
worked in neurosurgery and neurological care. Two 
other workers had been or were technicians at pathol-
ogy laboratories.
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Table 1
Occupational profile of sporadic Creutzfeldt–Jakob disease cases reported to the European Creutzfeldt Jakob Disease 
Surveillance Network (EuroCJD), 1965–2010 (n=8,321)
Occupation Number of sCJD cases, by countrya, in the specified time period
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To
ta
l
19
83
–2
00
9
19
70
–2
00
8
19
93
–2
00
8
19
97
–2
00
9
19
98
–2
00
9
19
95
–2
00
9
19
97
–2
00
9
19
93
–2
00
8
19
94
–2
00
7
19
94
–2
00
9
19
65
–2
00
7
19
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–2
00
8
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–2
00
9
19
93
–2
00
8
19
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93
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01
0
19
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00
9
19
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–2
00
9
19
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–2
00
7
19
93
–2
00
9
19
80
–2
00
9
Physicians or dentists
   Cardiovascular surgeon 0 0 0 - - - - - 0 0 0 0 1 0 0 0 0 0 - 0 0 1
   Surgeon/urologist 1 0 0 - - - - - 1 0 0 0 0 0 0 0 0 0 - 0 0 2
   Surgeon and neuropathologist 0 0 0 - - - - - 1 0 0 0 0 0 0 0 0 0 - 0 0 1
   Traumatologist/surgeon 1 0 0 - - - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 1
   Ophthalmologist 0 0 0 - - - - - 0 1 0 1 0 0 0 0 0 1 - 0 0 3
   Surgeon (not specified) 0 0 0 - - - - - 0 0 0 0 0 0 0 0 0 1 - 0 0 1
   Pathologist 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1
   Neuropathologist’s assistant 0 0 0 - - - - - 1 0 0 0 0 0 0 0 0 0 - 0 0 1
   Forensic medicine 0 0 0 - - - - - 0 0 0 1 0 0 0 0 0 0 - 0 0 1
   Dentist 1 0 1 - - - - - 0 0 2 0 0 0 0 0 0 0 - 0 0 4
   Traumatologist 1 0 0 - - - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 1
   Plastic surgeon 0 0 0 - - - - - 0 0 0 0 0 0 0 0 0 1 - 0 0 1
   Paediatrics/anatomy 0 0 0 - - - - - 0 0 0 0 0 0 0 0 0 0 - 0 1 1
   Cardiologist 0 1 0 - - - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 1
   Internist 0 0 2 - - - - - 2 0 0 3 0 0 0 0 0 0 - 0 0 7
   Clinical oncologist 1 0 0 - - - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 1
   Toxicologist 0 1 0 - - - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 1
   General practitioner 0 3 0 - - - - - 0 0 1 3 0 0 0 0 0 1 - 0 1 9
   Psychiatrist 0 0 0 - - - - - 0 0 0 0 1 0 0 0 0 0 - 0 0 1
   Paediatrician 1 0 0 - - - - - 0 0 0 0 0 0 0 0 0 0 - 0 0 1
   Radiologist 0 0 0 - - - - - 0 0 0 0 0 0 0 0 0 0 - 0 1 1
   Scientist 0 0 0 - - - - - 0 1 0 0 0 0 0 0 0 0 - 0 0 1
   National service medical corps 0 0 0 - - - - - 0 0 0 0 0 0 0 0 0 0 - 0 1 1
   Alternative medical practitioner 0 0 0 - - - - - 2 0 0 0 0 0 0 0 0 0 - 0 0 2
   Epidemiologist 0 0 0 - - - - - 0 0 0 0 0 0 0 1 0 0 - 0 0 1
   Geriatrician 0 0 0 - - - - - 0 0 1 0 0 0 0 0 0 0 - 0 0 1
   Virologist 0 0 0 - - - - - 0 0 1 0 0 0 0 0 0 0 - 0 0 1
   Other (specialisation not specified) 0 0 0 - - - - 9 0 0 0 4 0 0 0 0 0 4 - 0 0 17
   Number of sCJD cases 
   among physicians or dentists 6 5 3 - - - - 9 7 2 5 12 2 0 0 1 0 9 - 0 4 65
Other health professionals
   Laboratory technician 0 - 0 - - - - - - 0 0 1 1 1 - 0 0 - - - 2 5
   Sterilisation department 0 - 0 - - - - - - 0 0 0 0 1 - 0 0 - - - 0 1
   Veterinarian 1 - 0 - - - - - - 1b 0 1 0 0 - 0 0 - - - 0 3
   Hospital employee 1 - 0 - - - - - - 0 0 2 0 0 - 0 0 - - - 5 8
   Other 0 - 0 - - - - - - 1b 0 17 17 0 - 2 2 - - - 45 84
   Number of sCJD cases among all   
   other health professionals 2 - 0 - - - - 36 - 2 0 21 18 2 - 2 2 - - - 52 137
Number of sCJD cases among all 
healthcare professionals 8 5 3 - - - - 45 7 4 5 33 20 2 - 3 2 9 - - 56 202
Total number of  
registered sCJD casesc 20
6d
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16
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18
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40
6f 9f 88
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2
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5
13
3
77
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AR=Argentina, AU= Australia, AT=Austria, BE=Belgium, CA=Canada. CY=Cypus, DK=Denmark, FR=France, DE=Germany, HU=Hungary, IL=Israel, IT=Italy, 
JP= Japan, NL=Netherlands, PT=Portugal, SK=Slovakia,SL=Slovenia, ES=Spain, SE=Sweden, CH=Switzerland, UK=United Kingdom. 
    sCJD: sporadic Creutzfeldt–Jakob disease. The dashes represent years for which there are no data.
       a There were no reports of sCJD among Polish pathologists, clinicians or medical technicians (personal communication, Dr J. Kulczycki, May 2009)./ 
b The two (non-medical) health workers were pathology assistants./ c Data for countries reporting presence versus absence of sCJD among pathologists 
(Belgium, Canada, Cyprus, Denmark and Sweden) are not included in the total number./ d Confirmed or probable cases./ e Austria reported 233 sCJD cases 
during 1969 to 2009 (one genetic transmissible spongiform encephalopathy excluded), including 84 cases of sCJD with occupational data (1993–2008). / 
f  sCJD deaths obtained from the EuroCJD website [16].Otherwise different categories of registered sCJD on request./ g sCJD cases with occupational data 
only./ h Occupational data not registered.
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Only one of three case–control studies [4,5,21] pro-
vided data on specialities but gave no indication of the 
numbers involved [5]. It is likely that most cases men-
tioned in the EuroCJD study by Van Duijn et al. [5] were 
included in country-specific occupational counts of the 
case set obtained from the extended EuroCJD consor-
tium in response to the current request.
Health-related occupational risk of sCJD
The nine analytical papers on occupations and sCJD 
identified [3-7,19,21,25,26] tended to focus on health-
care and animal care-related occupations, with Cocco 
et al.’s study furnishing detailed data on other occupa-
tions [19]. This study used a large number of non-vali-
dated CJD diagnoses from death records in the United 
States and controls selected after exclusion of persons 
with neurological diseases reported as the cause of 
death [19]. The main findings for healthcare-related 
occupations from five papers are summarised in Table 
4. While three of four studies on health professions 
did not demonstrate excess risk [5-7], statistically sig-
nificant findings – for persons working at physicians’ 
offices – were solely reported by Cocco et al. [19].
Discussion 
Despite a number of case reports of sCJD in physicians 
and technicians, the findings of this EuroCJD survey do 
not suggest an increased risk of sCJD in health profes-
sionals, nor do analytical studies show a clear excess 
risk for health-related professions. Methodological 
limitations of analytical studies in which occupational 
data were frequently provided by informants who were 
probably aware of the sCJD diagnosis [3-7,26] argue in 
favour of a cautious interpretation of the positive asso-
ciation reported for persons working at physicians’ 
offices [19]. Consequently, the main finding of this 
literature review and complementary EuroCJD obser-
vation is that health professionals, including medi-
cal staff, are not at greater risk of developing sCJD. 
However, this cannot exclude the possibility that there 
may be an occupational risk in specific circumstances, 
for example, for people in contact with high-risk cen-
tral nervous system tissue, and appropriate precau-
tions, as recommended by national authorities, should 
therefore be followed, particularly regarding labora-
tory work.
Although in some studies occupation was specifically 
analysed [19,25] and occupation may be the subject of 
specific inquiry in some surveillance systems, a limi-
tation of some registries and scientific studies is that 
occupation may not have been systematically recorded. 
When occupation was recorded, it is unlikely that a 
framework for consistent occupational data collection 
was used, so that neither registries nor case–control 
studies have incorporated the classic epidemiologi-
cal double approach. Recording of occupation may 
not identify specific chemical or biological exposures, 
which would require data for professions (job titles, 
medical specialisations) being cross-referenced with 
branches of activity (laboratory, administrative or 
clinical patient-contact work). The lack of registered 
surveillance data that combine profession with activity 
(e.g. contact with human tissue), when compared with 
the descriptions from previous case reports and the 
incident in Spain, illustrates the limits of the validity 
of available data for analytical purposes and precludes 
formal use of statistical testing. Although our study 
does not provide evidence of an excess risk of sCJD in 
health professionals, the fact that the data collected 
were mainly linked to medical speciality rather than 
actual activity might have concealed an excess risk of 
sCJD for some specific health professionals.
A case–control study seeking to examine the putative 
occupational risk posed by surgical injuries should 
have a biologically clear working hypothesis and a 
custom-tailored methodology. Matrices designed 
by linking medical speciality and surgical/forensic-
anatomical/pathological activity, in which the health 
Table 2
Occupational profile of non-cases or controls obtained 
through the European Creutzfeldt Jakob Disease 
Surveillance Network (EuroCJD), 1980–2009 (n=2,968)
Occupation Number of professionals, 
by country, in the 
specified time period
DE IT JP ES
 
UK
To
ta
l
19
94
–2
00
7
19
93
–2
00
8
19
99
–2
00
9
19
93
–2
00
9
19
80
–2
00
9
Physicians
Traumatologist/surgeon 0 1 0 0 0 1
Surgeon (not specified) 0 1 0 0 1 2
Internist 0 1 0 0 0 1
General practitioner 0 1 0 0 1 2
Psychiatrist 0 0 0 1 0 1
Paediatrician 1 0 0 0 0 1
Scientist 0 0 0 0 1 1
Other (specialisation not specified) 6 0 0 0 0 6
Number of physicians 7 4 0 1 3 15
Other health professionals
Laboratory technician - 2 - - 5 7
Hospital employee - 1 - - 13 14
Other - 10 - - 34 44
Number of other health  
professionals - 13 3 - 52 68
Number of healthcare professionals 7 17 3 1 55 83
Total number of  
non-cases or controls 1,
06
1a
65
6b
26
8
16
7
81
6a
,b
2,
96
8
DE=Germany; IT=Italy ; JP=Japan; ES=Spain; UK=United Kingdom.
The dashes represent years for which there are no data.
a  Controls from own case–control study.
b  Only persons with occupational data.
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professional can come into direct contact with high 
human-infectivity tissue by accident might not provide 
a sufficient background for analysis, without appro-
priate control being made for the influence of PRNP 
genotype, surgical or laboratory work history and long 
latency. Assuming that among non-cases or controls 
the proportion of medical specialities with potential 
exposure (surgeons, forensic surgeons and other sur-
gical specialists, pathologists) may be low, i.e. approx-
imately 1 per 1,000 (based on the figures of 3/2,968 in 
Table 2), the study size that would afford the necessary 
statistical power for a proper examination of the spe-
cific practices of health professions is higher than that 
provided by existing CJD registries in any one country. 
Since complementary analyses would be needed for 
professional and activity categories defined in terms 
of temporal references that have not been explored to 
date, such as ‘ever employed’ or ‘currently employed’, 
as well as duration of employment, requirements for 
study size and collaboration would be even higher.
In conclusion, a wide spectrum of medical specialities 
and health professions are represented in sCJD regis-
tries. Although selection due to higher ascertainment 
may lie behind the case reports of certain professions 
involved in clinical management or care of patients 
with sCJD, the biological significance of these obser-
vations remains uncertain and available data do not 
indicate an increased risk of sCJD in health profession-
als. However, the methodological issues mentioned 
above indicate the need for caution in drawing con-
clusions from the data and large-scale studies with 
specific causal hypotheses are needed in order for fur-
ther research to be undertaken into the potential link 
between health professions and sCJD
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Table 4
Summary of methods and main results of analytical epidemiological research into healthcare-related occupations and 
sporadic Creutzfeldt–Jakob disease, literature review, 1982–1 October 2011  
CJD: Creutzfeldt–Jakob disease; EuroCJD: European Creutzfeldt Jakob Disease Surveillance Network; GP: general practitioner; OR: odds ratio
UK: United Kingdom; USA: United States of America.
a The information on health-related occupations from this study was not included in the meta-analysis [6].
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